Literature DB >> 11015423

Molecular analysis of methicillin-resistant Staphylococcus aureus as a causative agent of bronchopulmonary infection: relation to colonization in the upper respiratory tract.

H Watanabe1, H Masaki, N Asoh, K Watanabe, K Oishi, S Kobayashi, A Sato, T Nagatake.   

Abstract

Using five diagnostic markers, we compared the types of 72 strains of methicillin-resistant Staphylococcus aureus (MRSA) isolated simultaneously from the nasal cavity, pharynx, and sputum from 24 patients. Almost identical MRSA types had colonized the nasal cavity and sputum from the same patient for 21 (88%) of the patients. We speculate that most MRSA organisms isolated in sputum are derived from the nasal cavity, while a few are derived from the pharynx.

Entities:  

Mesh:

Year:  2000        PMID: 11015423      PMCID: PMC87496     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  MRSA meningitis in postoperative patients. Report of 4 cases.

Authors:  T Sakamoto; K Kikuchi; K Mineura; M Kowada; O Nakagomi
Journal:  Jpn J Antibiot       Date:  1990-06

2.  Association of respiratory tract colonization with adherence of gram-negative bacilli to epithelial cells.

Authors:  W G Johanson; D E Woods; T Chaudhuri
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

3.  Clinical and epidemiologic investigations of nosocomial pulmonary infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  T Iwahara; S Ichiyama; T Nada; K Shimokata; N Nakashima
Journal:  Chest       Date:  1994-03       Impact factor: 9.410

4.  Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization.

Authors:  L Fierobe; D Decré; C Mùller; J C Lucet; J P Marmuse; J Mantz; J M Desmonts
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

5.  Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus.

Authors:  T L Bannerman; G A Hancock; F C Tenover; J M Miller
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

6.  Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures.

Authors:  R P Wenzel; M D Nettleman; R N Jones; M A Pfaller
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

7.  Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

Authors:  R Sutherland; R J Boon; K E Griffin; P J Masters; B Slocombe; A R White
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.

Authors:  R L Hill; G J Duckworth; M W Casewell
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

9.  The role of MRSA (methicillin-resistant Staphylococcus aureus) adherence and colonization in the upper respiratory tract of geriatric patients in nosocomial pulmonary infections.

Authors:  N Rikitomi; T Nagatake; T Sakamoto; K Matsumoto
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

10.  Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.

Authors:  J Rello; A Torres; M Ricart; J Valles; J Gonzalez; A Artigas; R Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405

View more
  2 in total

1.  Molecular evidence that nasal carriage of Staphylococcus aureus plays a role in respiratory tract infections of critically ill patients.

Authors:  Philippe Corne; Hélène Marchandin; Olivier Jonquet; Josiane Campos; Anne-Laure Bañuls
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  H Watanabe; H Masaki; N Asoh; K Watanabe; K Oishi; S Kobayashi; A Sato; R Sugita; T Nagatake
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.